This inventor holds 1 USPTO granted patent. Top assignee: Warner Lambert LLC. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Bernard Guadillière: Innovator in Pharmaceutical Chemistry
Introduction
Bernard Guadillière is a notable inventor based in Nanterre, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as phosphodiesterase inhibitors. His work is essential in advancing therapeutic options for various medical conditions.
Latest Patents
Guadillière holds a patent for "1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors." This innovative compound has the potential to impact the treatment of diseases by modulating enzyme activity in the body.
Career Highlights
He is currently associated with Warner Lambert LLC, a company known for its commitment to research and development in the pharmaceutical industry. His role at the company allows him to leverage his expertise in creating effective medicinal compounds.
Collaborations
Guadillière collaborates with various professionals in his field, including his coworker Remi Lavalette. Their combined efforts contribute to the advancement of pharmaceutical innovations.
Conclusion
Bernard Guadillière's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions through patents and collaborations continue to shape the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile